Sadiya S Khan1, Hongyan Ning2, Sanjiv J Shah3, Clyde W Yancy3, Mercedes Carnethon2, Jarett D Berry4, Robert J Mentz5, Emily O'Brien5, Adolfo Correa6, Navin Suthahar7, Rudolf A de Boer7, John T Wilkins8, Donald M Lloyd-Jones8. 1. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: s-khan-1@northwestern.edu. 2. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 3. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 4. Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas. 5. Duke Clinical Research Institute, Durham, North Carolina; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina. 6. Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi. 7. University Medical Centre Groningen, University of Groningen, Department of Cardiology, Groningen, the Netherlands. 8. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Abstract
BACKGROUND: Primary prevention strategies to mitigate the burden of heart failure (HF) are urgently needed. However, no validated risk prediction tools are currently in use. OBJECTIVES: This study sought to derive 10-year risk equations of developing incident HF. METHODS: Race- and sex-specific 10-year risk equations for HF were derived and validated from individual-level data from 7 community-based cohorts with at least 12 years of follow-up. Participants who were recruited between 1985 and 2000, between 30 to 79 years, and were free of cardiovascular disease at baseline were included to create a pooled cohort (PC) and were randomly split for derivation and internal validation. Model performance was also assessed in 2 additional cohorts. RESULTS: In the derivation sample of the PC (n = 11,771), 58% were women, 22% were black with a mean age of 52 ± 12 years, and HF occurred in 1,339 participants. Predictors of HF included in the race-sex-specific models were age, blood pressure (treated or untreated), fasting glucose (treated or untreated), body mass index, cholesterol, smoking status, and QRS duration. The PC equations to Prevent HF model had good discrimination and strong calibration in internal and external validation cohorts. A web-based tool was developed to facilitate clinical application of this tool. CONCLUSIONS: The authors present a contemporary analysis from 33,010 men and women demonstrating the utility of the sex- and race-specific 10-year PC equations to Prevent HF risk score, which integrates clinical parameters readily available in primary care settings. This tool can be useful in risk-based decision making to determine who may merit intensive screening and/or targeted prevention strategies.
BACKGROUND: Primary prevention strategies to mitigate the burden of heart failure (HF) are urgently needed. However, no validated risk prediction tools are currently in use. OBJECTIVES: This study sought to derive 10-year risk equations of developing incident HF. METHODS: Race- and sex-specific 10-year risk equations for HF were derived and validated from individual-level data from 7 community-based cohorts with at least 12 years of follow-up. Participants who were recruited between 1985 and 2000, between 30 to 79 years, and were free of cardiovascular disease at baseline were included to create a pooled cohort (PC) and were randomly split for derivation and internal validation. Model performance was also assessed in 2 additional cohorts. RESULTS: In the derivation sample of the PC (n = 11,771), 58% were women, 22% were black with a mean age of 52 ± 12 years, and HF occurred in 1,339 participants. Predictors of HF included in the race-sex-specific models were age, blood pressure (treated or untreated), fasting glucose (treated or untreated), body mass index, cholesterol, smoking status, and QRS duration. The PC equations to Prevent HF model had good discrimination and strong calibration in internal and external validation cohorts. A web-based tool was developed to facilitate clinical application of this tool. CONCLUSIONS: The authors present a contemporary analysis from 33,010 men and women demonstrating the utility of the sex- and race-specific 10-year PC equations to Prevent HF risk score, which integrates clinical parameters readily available in primary care settings. This tool can be useful in risk-based decision making to determine who may merit intensive screening and/or targeted prevention strategies.
Authors: Herman A Taylor; James G Wilson; Daniel W Jones; Daniel F Sarpong; Asoka Srinivasan; Robert J Garrison; Cheryl Nelson; Sharon B Wyatt Journal: Ethn Dis Date: 2005 Impact factor: 1.847
Authors: G F Diercks; W M Janssen; A J van Boven; A A Bak; P E de Jong; H J Crijns; W H van Gilst Journal: Am J Cardiol Date: 2000-09-15 Impact factor: 2.778
Authors: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel Journal: Lancet Date: 2002-03-23 Impact factor: 79.321
Authors: Ramachandran S Vasan; Emelia J Benjamin; Martin G Larson; Eric P Leip; Thomas J Wang; Peter W F Wilson; Daniel Levy Journal: JAMA Date: 2002-09-11 Impact factor: 56.272
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Peter A Glynn; Hongyan Ning; Aakash Bavishi; Priya M Freaney; Sanjiv Shah; Clyde W Yancy; Donald M Lloyd-Jones; Sadiya S Khan Journal: Am J Med Date: 2020-08-20 Impact factor: 4.965
Authors: Sadiya S Khan; Noam Barda; Philip Greenland; Noa Dagan; Donald M Lloyd-Jones; Ran Balicer; Laura J Rasmussen-Torvik Journal: Am J Cardiol Date: 2022-01-12 Impact factor: 2.778
Authors: Sadiya S Khan; Hongyan Ning; Norrina B Allen; Mercedes R Carnethon; Clyde W Yancy; Sanjiv J Shah; John T Wilkins; Lu Tian; Donald M Lloyd-Jones Journal: Circ Res Date: 2021-12-10 Impact factor: 17.367
Authors: Aakash Bavishi; Matthew Bruce; Hongyan Ning; Priya M Freaney; Peter Glynn; Faraz S Ahmad; Clyde W Yancy; Sanjiv J Shah; Norrina B Allen; Suma X Vupputuri; Laura J Rasmussen-Torvik; Donald M Lloyd-Jones; Sadiya S Khan Journal: Circ Heart Fail Date: 2020-10-23 Impact factor: 8.790
Authors: Matthew W Segar; Muthiah Vaduganathan; Kershaw V Patel; Darren K McGuire; Javed Butler; Gregg C Fonarow; Mujeeb Basit; Vaishnavi Kannan; Justin L Grodin; Brendan Everett; Duwayne Willett; Jarett Berry; Ambarish Pandey Journal: Diabetes Care Date: 2019-09-13 Impact factor: 19.112
Authors: Arjun Sinha; Deepak K Gupta; Clyde W Yancy; Sanjiv J Shah; Laura J Rasmussen-Torvik; Elizabeth M McNally; Philip Greenland; Donald M Lloyd-Jones; Sadiya S Khan Journal: Circ Heart Fail Date: 2021-02-04 Impact factor: 8.790
Authors: Amanda M Perak; Sadiya S Khan; Laura A Colangelo; Samuel S Gidding; Anderson C Armstrong; Cora E Lewis; Jared P Reis; Pamela J Schreiner; Stephen Sidney; Joao A C Lima; Donald M Lloyd-Jones Journal: J Am Soc Echocardiogr Date: 2020-11-17 Impact factor: 5.251